» Articles » PMID: 32782464

The Challenge of Recognising Sepsis: Future Nanotechnology Solutions

Overview
Publisher Sage Publications
Specialty Critical Care
Date 2020 Aug 13
PMID 32782464
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The urgent need to start anti-infective therapeutic interventions in suspected sepsis, and the lack of specific time-critical diagnostic information often lead to the widespread administration of broad-spectrum antimicrobial therapies, increasing the risk of unwanted patient harms and contributing to rising pathogen antimicrobial resistance. Nanotechnology, which involves engineering at the nanoscale, allows for the bespoke development of diagnostic solutions with multi-functionality and high sensitivity that has the potential to help provide time-critical information to make more accurate diagnoses and treatment decisions for sepsis. Nanotechnologies also have the potential to improve upon the current strategies used for novel biomarker discovery. Here we describe some of the current limitations to identifying sepsis and explore the potential role for nanotechnology solutions.

Citing Articles

Applications of peptides in nanosystems for diagnosing and managing bacterial sepsis.

Gafar M, Omolo C, Elhassan E, Ibrahim U, Govender T J Biomed Sci. 2024; 31(1):40.

PMID: 38637839 PMC: 11027418. DOI: 10.1186/s12929-024-01029-2.


Nanotechnology Applications in Sepsis: Essential Knowledge for Clinicians.

Vasconcelos I, Santos T Pharmaceutics. 2023; 15(6).

PMID: 37376129 PMC: 10302508. DOI: 10.3390/pharmaceutics15061682.


Effect of Selenium Nanoparticle Size on IL-6 Detection Sensitivity in a Lateral Flow Device.

Bradley Z, Coleman P, Courtney M, Fishlock S, McGrath J, Uniacke-Lowe T ACS Omega. 2023; 8(9):8407-8414.

PMID: 36910974 PMC: 9996617. DOI: 10.1021/acsomega.2c07297.


Nanomaterials targeting macrophages in sepsis: A promising approach for sepsis management.

Song C, Xu J, Gao C, Zhang W, Fang X, Shang Y Front Immunol. 2022; 13:1026173.

PMID: 36569932 PMC: 9780679. DOI: 10.3389/fimmu.2022.1026173.


Sepsis diagnosis and treatment using nanomaterials.

Lim J, Lee Y, Choy Y, Park W, Park C Biomed Eng Lett. 2021; 11(3):197-210.

PMID: 34277115 PMC: 8274966. DOI: 10.1007/s13534-021-00200-0.


References
1.
Lin H, Chen C, Chen Y . Detection of phosphopeptides by localized surface plasma resonance of titania-coated gold nanoparticles immobilized on glass substrates. Anal Chem. 2006; 78(19):6873-8. DOI: 10.1021/ac060833t. View

2.
Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

3.
Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R . Adjunctive Glucocorticoid Therapy in Patients with Septic Shock. N Engl J Med. 2018; 378(9):797-808. DOI: 10.1056/NEJMoa1705835. View

4.
Daniels R . Surviving the first hours in sepsis: getting the basics right (an intensivist's perspective). J Antimicrob Chemother. 2011; 66 Suppl 2:ii11-23. DOI: 10.1093/jac/dkq515. View

5.
Xu C, Chang A, Hack B, Eadon M, Alper S, Cunningham P . TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis. Kidney Int. 2013; 85(1):72-81. PMC: 3834073. DOI: 10.1038/ki.2013.286. View